Drano: Any visit to the swamp leaves me wanting to take a
Drano: Any visit to the swamp leaves me wanting to take a shower. Thankfully I am able to recognize the liars and understand that they are being paid to try and separate innocent investors from their hard earned money. I feel bad for these folks who have such little self respect they lie for a living 24/7 365 days a year. Imagine when asked their response as to what they do for a living? What do they tell family and what will they tell them when that inevitable knock on the door arrives and they are led away in cuffs? They must feel trapped in order to continue doing what they do. If they were smart they would file as a whisteblower and expose the whole scam that is the path they chose to follow.
We are fortunate here because CTIX has the science and the science will overcome the manipulators and the manipulators will pay dearly for having attacked CTIX. In the meantime there are some things we can do to make things more difficult for our enemy. We can put in GTC sell orders for part or all of our shares at what today are high prices. There is risk in doing this however as once Leo is able to announce the right news the demand for shares will cause them to rise dramatically in price so you must be able to monitor to remove the sell order or you could lose your shares. If you choose to do this place the GTC sell price at a price where you would not mind losing some of your position otherwise you are at risk.
Have an annual physical scheduled soon? Tell you Doctor about CTIX and its science and if you are of a mind bring a brief summary to give him.
With CTIX's science and the drugs in trials there is little risk to any funds he chooses to invest imho.
Last but not least is there one poster who really makes you angry reading his posts? If so print a couple out that really get your motor running and keep those posts nearby so that when the time comes and the shorts keep increasing the bid and begging us to sell them back some markers reading those posts will firm your resolve to make the SOB's pay dearly for their lies and trying to steal your funds. Go CTIX!!!
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Top 5 Most Recently Viewed Articles
JX Luxventure Secures Major $15 Million Deal JX Luxventure Group Inc. (NASDAQ: JXG), a pioneering technology company specializing in integrated tourism services, has entered into a significant cooperation agreement expected to transform its business landscape. This $15 million partnership is designed to enhance the company's cross-border e-commerce services, encompassing...
Continue Reading
Watsco Achieves Record Sales and Operating Efficiency In recent developments, Watsco, Inc. (NYSE: WSO) has successfully reported record sales alongside heightened operational efficiency. The company's robust performance during the last quarter illustrates its strength and continued growth trajectory within the HVAC/R market. The HVAC/R Market Landscape The HVAC/R sector,...
Continue Reading
Excelerate Energy's Upcoming Earnings Call Excelerate Energy, Inc. (NYSE: EE) has announced its plans for the release of its fourth quarter and full year 2024 results. This highly anticipated information will be made available to the public on February 26, 2025, right after the U.S. financial markets close. As one of the leaders in the LNG industry, the Company is...
Continue Reading
LIS Technologies Takes Charge at Advanced Reactor Summit XII In a significant development for the nuclear energy sector, LIS Technologies Inc. (LIST), a distinguished name in advanced laser technology, has proudly announced its role as the lead sponsor for the forthcoming Advanced Reactor Summit XII. The event, organized by the United States Nuclear Industry Council...
Continue Reading
The Growing Electric Vehicle Market: A Comprehensive Overview The global electric vehicle market is undergoing a significant transformation, anticipated to expand notably from its valuation in 2024. Forecasts indicate a leap from USD 328.73 billion to a staggering USD 4,309.65 billion by 2033. This growth trajectory is fueled largely by increasing concerns regarding air...
Continue Reading